85 related articles for article (PubMed ID: 34211933)
1. Comparison of the effect of insulin glargine and regular insulin on perioperative glycemic control in patients with type 2 diabetes mellitus under insulin treatment during vitrectomy surgery under general anesthesia: A randomized clinical trial study.
Derakhshan P; Khatibi A; Faiz SHR; Rahimzadeh P; Nouri N
Med J Islam Repub Iran; 2021; 35():31. PubMed ID: 34211933
[No Abstract] [Full Text] [Related]
2. Comparison of once-daily glargine insulin with twice-daily NPH/regular insulin for control of hyperglycemia in inpatients after cardiovascular surgery.
Yeldandi RR; Lurie A; Baldwin D
Diabetes Technol Ther; 2006 Dec; 8(6):609-16. PubMed ID: 17109592
[TBL] [Abstract][Full Text] [Related]
3. Metformin as an adjunct to insulin for glycemic control in patients with type 2 diabetes after CABG surgery: a randomized double blind clinical trial.
Baradari AG; Emami Zeydi A; Aarabi M; Ghafari R
Pak J Biol Sci; 2011 Dec; 14(23):1047-54. PubMed ID: 22590838
[TBL] [Abstract][Full Text] [Related]
4. Effects of glargine on hyperglycemia in patients with diabetes mellitus type II undergoing off-pump coronary artery bypass graft: A randomized, controlled, double-blind clinical trial.
Sheybani S; Kahrom M; Ganjali R; Kalati SM; Zirak N; Ghorani V
J Cardiovasc Thorac Res; 2023; 15(1):44-50. PubMed ID: 37342663
[No Abstract] [Full Text] [Related]
5. Effect of basal insulin dosage on blood glucose concentration in ambulatory surgery patients with type 2 diabetes.
Demma LJ; Carlson KT; Duggan EW; Morrow JG; Umpierrez G
J Clin Anesth; 2017 Feb; 36():184-188. PubMed ID: 28183563
[TBL] [Abstract][Full Text] [Related]
6. Glycemic Control in Adult Surgical Patients Receiving Regular Insulin Added to Parenteral Nutrition vs Insulin Glargine: A Retrospective Chart Review.
Truong S; Park A; Kamalay S; Hung N; Meyer JG; Nguyen N; Momenzadeh A
Nutr Clin Pract; 2019 Oct; 34(5):775-782. PubMed ID: 30693980
[TBL] [Abstract][Full Text] [Related]
7. Effect of Adding Insulin Glargine on Glycemic Control in Critically Ill Patients Admitted to Intensive Care Units: A Prospective Randomized Controlled Study.
Nader ND; Hamishehkar H; Naghizadeh A; Shadvar K; Iranpour A; Sanaie S; Chang F; Mahmoodpoor A
Diabetes Metab Syndr Obes; 2020; 13():671-678. PubMed ID: 32210600
[TBL] [Abstract][Full Text] [Related]
8. Glargine Insulin Use Versus Continuous Regular Insulin in Diabetic Surgical Noncritically Ill Patients Receiving Parenteral Nutrition: Randomized Controlled Study.
Hakeam HA; Mulia HA; Azzam A; Amin T
JPEN J Parenter Enteral Nutr; 2017 Sep; 41(7):1110-1118. PubMed ID: 27091835
[TBL] [Abstract][Full Text] [Related]
9. Once-daily insulin glargine versus 6-hour sliding scale regular insulin for control of hyperglycemia after a bariatric surgical procedure: a randomized clinical trial.
Datta S; Qaadir A; Villanueva G; Baldwin D
Endocr Pract; 2007; 13(3):225-31. PubMed ID: 17599852
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Glycemic Variability in Chinese T2DM Patients Treated with Exenatide or Insulin Glargine: A Randomized Controlled Trial.
Yin TT; Bi Y; Li P; Shen SM; Xiong XL; Gao LJ; Jiang C; Wang Y; Feng WH; Zhu DL
Diabetes Ther; 2018 Jun; 9(3):1253-1267. PubMed ID: 29744819
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Glycemic Control between Continuous Regular Insulin Infusion and Single-dose Subcutaneous Insulin Glargine Injection in Medical Critically Ill Patients.
Bhurayanontachai R; Rattanaprapat T; Kongkamol C
Indian J Crit Care Med; 2018 Mar; 22(3):174-179. PubMed ID: 29657375
[TBL] [Abstract][Full Text] [Related]
12. A Randomized Clinical Trial of Insulin Glargine and Aspart, Compared to NPH and Regular Insulin in Children with Type 1 Diabetes Mellitus.
Rostami P; Setoodeh A; Rabbani A; Nakhaei-Moghadam M; Najmi-Varzaneh F; Rezaei N
Iran J Pediatr; 2014 Apr; 24(2):173-8. PubMed ID: 25535536
[TBL] [Abstract][Full Text] [Related]
13. The Durability of Basal Insulin Affects Day-to-Day Glycemic Variability Assessed by Continuous Glucose Monitoring in Type 2 Diabetes Patients: A Randomized Crossover Trial.
Iuchi H; Sakamoto M; Matsutani D; Suzuki H; Horiuchi R; Utsunomiya K
Diabetes Technol Ther; 2017 Aug; 19(8):457-462. PubMed ID: 28605286
[TBL] [Abstract][Full Text] [Related]
14. Glargine insulin for treatment of naturally occurring diabetes mellitus in dogs.
Hess RS; Drobatz KJ
J Am Vet Med Assoc; 2013 Oct; 243(8):1154-61. PubMed ID: 24094263
[TBL] [Abstract][Full Text] [Related]
15. Insulin Glargine in Critically ill Patients: Once/Day versus Twice/Day Dosing.
Fox MA; Perry MC; Liu-DeRyke X
Pharmacotherapy; 2020 Mar; 40(3):186-190. PubMed ID: 31995840
[TBL] [Abstract][Full Text] [Related]
16. Spotlight on insulin glargine in type 1 and 2 diabetes mellitus.
McKeage K; Goa KL
Treat Endocrinol; 2002; 1(1):55-8. PubMed ID: 15765621
[TBL] [Abstract][Full Text] [Related]
17. Degludec is superior to glargine in terms of daily glycemic variability in people with type 1 diabetes mellitus.
Yamamoto C; Miyoshi H; Fujiwara Y; Kameda R; Ichiyama M; Nomoto H; Kameda H; Nakamura A; Atsumi T
Endocr J; 2016; 63(1):53-60. PubMed ID: 26522272
[TBL] [Abstract][Full Text] [Related]
18. Once-daily insulin glargine compared with twice-daily NPH insulin in patients with type 1 diabetes.
Hershon KS; Blevins TC; Mayo CA; Rosskamp R
Endocr Pract; 2004; 10(1):10-7. PubMed ID: 15251616
[TBL] [Abstract][Full Text] [Related]
19. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial).
Umpierrez GE; Smiley D; Zisman A; Prieto LM; Palacio A; Ceron M; Puig A; Mejia R
Diabetes Care; 2007 Sep; 30(9):2181-6. PubMed ID: 17513708
[TBL] [Abstract][Full Text] [Related]
20. Glycemic control with use of insulin glargine after cardiothoracic surgery: a retrospective study.
Ergin AB; Nasr G; Yared JP; Bena J; Nasr C
Endocr Pract; 2013; 19(3):485-93. PubMed ID: 23425653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
